סינרייז

País: Israel

Língua: hebraico

Origem: Ministry of Health

Compre agora

Ingredientes ativos:

C - 1 ESTERASE INHIBITOR HUMAN 500 UNITS

Disponível em:

NEOPHARM CURE (2005) LTD

Código ATC:

B02AB03

Forma farmacêutica:

LYOPHILIZED POWDER FOR SOLUTION FOR INJECTION

Via de administração:

I.V

Fabricado por:

SANQUIN BLOOD SUPPLY FOUNDATION, THE NETHERLANDS

Grupo terapêutico:

C1-INHIBITOR

Indicações terapêuticas:

Treatment and pre-procedure prevention of angioedema attacks in adults and adolescents with hereditary angioedema (HAE). Routine prevention of angioedema attacks in adults and adolescents with severe and recurrent attacks of hereditary angioedema (HAE), who are intolerant to or insufficiently protected by oral prevention treatments, or patients who are inadequately managed with repeated acute treatment.

Data de autorização:

2013-08-01

Pesquisar alertas relacionados a este produto

Ver histórico de documentos